LIN-2102
/ Linno Pharmaceuticals
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
April 29, 2026
SLN12140 in Adult Participants With IgA Nephropathy in China
(clinicaltrials.gov)
- P2 | N=48 | Not yet recruiting | Sponsor: Linno Pharmaceuticals, Inc.
New P2 trial • Glomerulonephritis • IgA Nephropathy • Renal Disease
February 05, 2026
SLN12140 in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) in China
(clinicaltrials.gov)
- P2 | N=10 | Not yet recruiting | Sponsor: Linno Pharmaceuticals, Inc.
New P2 trial • Complement-mediated Rare Disorders • Hematological Disorders • Paroxysmal Nocturnal Hemoglobinuria • Rare Diseases
1 to 2
Of
2
Go to page
1